Document Detail


Combinatorial code of growth factors and neuropeptides define neuroendocrine differentiation in PC12 cells.
MedLine Citation:
PMID:  14637105     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Adrenal chromaffin cells constitute one of the first cell types to have been defined as a neuroendocrine cell type. Since they produce dopamine, these cells have been proposed for the treatment of neuronal deficits in human Parkinson's disease. However, the factors involved in the development of chromaffin cells are still poorly understood. Based on recent insights from stem cell research, we decided to study the role of extracellular matrices, growth factors and neuropeptides on the neuroendocrine differentiation in a serum-free medium of PC12 cells. Employing immunohistochemistry, quantitative PCR and HPLC analysis, neuroendocrine differentiation was determined by evaluating neurite outgrowth, catecholamine biosynthesis and release as well as neuropeptide and vesicular protein mRNA expression. The combination of bFGF, NGF and PACAP could prevent the inhibition of neurite process development induced by dexamethasone in PC12 cells cultured on ECM. Whereas glucocorticoids were essential in the regulation of enzymes of catecholamine biosynthesis and metabolism, growth factors and PACAP were more efficient in inducing neuropeptide and chromogranin B expression as well as release of dopamine and 3-methoxytyramine. Therefore, in addition to glucocorticoids, chromaffin cells need a gradient of matrix, growth factors, and neuropeptides to develop the full functional phenotype of a neuroendocrine cell.
Authors:
Delphine Beaujean; Claudia Rosenbaum; Hans-Werner Müller; Jacques J Willemsen; Jacques Lenders; Stefan R Bornstein
Related Documents :
22173495 - Re-expression of cell adhesion molecule inhibits growth and induces apoptosis of human ...
1964795 - Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma...
10650885 - Retroviral transfer of the beta-nerve growth factor gene into murine neuroectodermal tu...
2169895 - 1,25-dihydroxyvitamin d-3 and 24,25-dihydroxyvitamin d-3 affect parathormone (pth) -sen...
22507855 - Induced pluripotent stem cells without c-myc attenuate acute kidney injury via down-reg...
3023835 - Expression of viral p21ras during acquisition of a transformed phenotype by rat adrenal...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Experimental neurology     Volume:  184     ISSN:  0014-4886     ISO Abbreviation:  Exp. Neurol.     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2003-11-25     Completed Date:  2004-01-05     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0370712     Medline TA:  Exp Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  348-58     Citation Subset:  IM    
Affiliation:
Department of Endocrinology, University of Düsseldorf, 40225, Düsseldorf, Germany. delphine.beaujean@univ-rouen.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Catecholamines / biosynthesis,  metabolism
Cell Differentiation / physiology
Cell Survival / physiology
Chromatography, High Pressure Liquid
Culture Media, Serum-Free
Dexamethasone / pharmacology
Extracellular Matrix / physiology
Growth Substances / biosynthesis*
Immunohistochemistry
Nerve Tissue Proteins / biosynthesis
Neurites / physiology
Neuropeptides / biosynthesis*,  pharmacology
Neurosecretory Systems / cytology,  physiology*
PC12 Cells
Pituitary Adenylate Cyclase-Activating Polypeptide
RNA, Messenger / biosynthesis
Rats
Reverse Transcriptase Polymerase Chain Reaction
Chemical
Reg. No./Substance:
0/Adcyap1 protein, rat; 0/Catecholamines; 0/Culture Media, Serum-Free; 0/Growth Substances; 0/Nerve Tissue Proteins; 0/Neuropeptides; 0/Pituitary Adenylate Cyclase-Activating Polypeptide; 0/RNA, Messenger; 50-02-2/Dexamethasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Zinc released from metallothionein-iii may contribute to hippocampal CA1 and thalamic neuronal death...
Next Document:  PARP cleavage, DNA fragmentation, and pyknosis during excitotoxin-induced neuronal death.